To preliminarily evaluate the potential clinical relevance of our laboratory findings in neuroblastoma patients, we investigated the correlation of neuroblastoma tumor CDKN3 mRNA expression with patient survival. This evidence concerns the gene CDKN3 and neuroblastoma.